Committee advances bill updating diabetes equipment coverage to include pumps, CGMs and smart pens

The House committee advanced HB2083 as amended to expand health-plan coverage for diabetes management devices, including continuous glucose monitors (CGMs), insulin pumps and smart insulin pens.

Julie Hoffman, chair of advocacy for the American Diabetes Association Desert Southwest and the Arizona Diabetes Coalition Leadership Council, told members the amendment updates statute to reflect modern clinical standards and would not remove medical-necessity determinations. ‘‘These are the textbook basics most commonly prescribed and life saving to people with diabetes,’’ Hoffman said.

Gina Swoboda, a parent whose child uses diabetes technology, described the real-world benefits of alerts and remote monitoring for families and urged lawmakers to reduce barriers to access. Supporters stressed long-term savings by avoiding complications such as dialysis and vision loss.

Mark Osborne, representing Blue Cross Blue Shield, said he was in soft opposition, warning that codifying coverage in statute could trigger federal ACA-related state mandate liability and potential costs; he urged additional stakeholder discussions and offered a narrow drafting approach focused on insulin rather than broader injectables.

Committee members discussed clarifying statutory language to avoid unintended coverage mandates for non-diabetes injectables and asked insurers and advocates to negotiate floor amendments. The committee adopted the Bliss strike-everything amendment and returned HB2083 as amended with a due-pass recommendation (roll-call: 11 ayes, 1 nay).